Latest Breaking News On - Riboscience llc - Page 1 : comparemela.com

/PRNewswire/ Riboscience, LLC, today announced the first presentation of data from the ongoing Phase 1 clinical trial of the ENPP1 inhibitor RBS2418 that.

New yorkUnited statesKlaus klumppThomasu marronEuropean society for medical oncologyPrnewswire riboscienceMount sinaiEuropean societyMedical oncologySubjects withMetastatic tumorsText viewPrivate securities litigation reform actRiboscience llcHealth care amp hospitalsMedical pharmaceuticals